ent-Abacavir EP Impurity D
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

2079853-44-2ent-Abacavir EP Impurity D

● 재고 있음

카탈로그 번호:VE0025011
CAS 번호:2079853-44-2
분자식:C14H18N6O
분자량:286.34 g/mol

에 대한 추가 정보 CAS 2079853-44-2

모약물

Abacavir

IUPAC명

((1S, 4S)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol

약전 동의어

N/A

Other Synonyms

N/A

SMILES

OC[C@@H]1C=C[C@@H](N2C=NC3=C(NC4CC4)N=C(N)N=C23)C1

InChI

InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1, 4, 7-10, 21H, 2-3, 5-6H2, (H3, 15, 17, 18, 19)/t8-, 10-/m1/s1

설명

ent-Abacavir EP Impurity D (CAS 2079853-44-2) is a stereochemical impurity encountered during synthesis and storage of abacavir. Analytical characterization typically employs chiral HPLC and LC-MS with confirmatory NMR to define retention behavior | mass fragments and stereochemical configuration. This low-level enantiomeric impurity can arise from epimerization or incomplete stereoselective synthesis and has implications for potency | stability and regulatory compliance. Robust impurity profiling | validated chiral analytical methods | targeted degradation studies and tight specification limits are recommended to monitor and control its presence in drug substance and formulation. Data-driven risk assessment supports appropriate acceptance criteria and mitigation strategies.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url